*Trypanosoma cruzi,* the causative agent of Chagas disease, has been divided into six discrete taxonomic units (DTUs) named *T. cruzi* I-VI ([@B26]). Recently, many authors have attempted to determine the geographical distribution of *T. cruzi* DTUs and their relationships with transmission dynamics and clinical outcomes. As summarised by Vallejo et al. (2009a), studies using TCC/TC1/TC2 primers designed for the spliced-leader intergenic region (SL-IR) ([@B18]) have demonstrated that *T. cruzi* I predominates in Colombian domestic and sylvatic vectors, with 2.1-78.6% having been detected in naturally-infected *Rhodnius prolixus*, *Rhodnius colombiensis* and *Rhodnius pallescens* mid-gut specimens. Studies of Colombian Chagas disease patients have also revealed the predominance of *T. cruzi* I over other DTUs in blood and tissue explants ([@B25], [@B24], [@B08], [@B16]).

Although there is a current consensus regarding the predominance of *T. cruzi* I in Colombian, Venezuelan and Central American countries, *T. cruzi* I has tremendous genetic variability, as demonstrated by several molecular markers ([@B05]). Based on the SL-IR region, four *T. cruzi* I genotypes associated with Chagas disease transmission cycles have been described in Colombia (Ia, Ib, Ic, Id) and corroborated through the American continent by the detection of a novel genotype, named *T. cruzi* Ie, associated with *Mepraia* species in Bolivia and Chile ([@B06], [@B07], [@B02]). Specific primers have also been developed to identify three of these four genotypes (Ia, Ib and Id) ([@B03]). Other molecular markers have confirmed the intraspecific variability within *T. cruzi* I, suggesting the emergence of novel genotypes such as a TcI clade, which has been named TcI~DOM~ (formerly TcIa⁄VEN~DOM~) and is associated with the domestic transmission cycle throughout the American continent ([@B15]). Several authors have thus proposed the separation of the two main *T. cruzi* I groups based on associations with domestic and sylvatic cycles ([@B06], [@B09], [@B13], [@B14]).

The domestic and sylvatic cycles of *T. cruzi* are not strictly separated. Several reports have shown that sylvatic triatomines can invade housing units and contaminate food with *T. cruzi*, causing outbreaks of \"oral Chagas disease\". For example, the application of high-resolution molecular markers to biological clones from strains isolated during such outbreaks have incriminated *T. cruzi* I sylvatic strains and clones as causal agents of oral Chagas disease outbreaks in Colombia ([@B17]). This association between domestic and sylvatic cycles in *T. cruzi* I highlights the potential for further research in this field. The objective of this present study was to develop a method for single polymerase chain reaction (PCR) amplification of the SL-IR to discriminate between domestic and sylvatic genotypes and to obtain a better understanding of domestic and sylvatic cycles as well as the transmission dynamics of this DTU.

SL-IR sequences (accessions AM259467-AM259477 and EU626722-EU626738) were retrieved from GenBank and subsequently aligned. The 1Am primer (5\'-TGTGTGTGTATGTATGTG-3\') was designed and used with primer 1B (5\'-CGGAGCGGTGTGTGCAG-3\') (Falla et al. 2009) to perform PCR reactions in a total volume of 20 µL containing 2 µL of 10X reaction buffer (Invitrogen), 200 µM of a mixture of deoxynucleotide triphosphates, 1.5 mM MgCl~2~ *,* 25 µM each primer, 0.5 units of *Taq* DNA polymerase (Invitrogen). The template (20 ng) included DNA from a strain or clone previously characterised as *T. cruzi* I using different molecular markers, including multilocus enzyme electrophoresis or PCR of large subunit rDNA ([@B18]), PCR-restriction fragment length polymorphism (RFLP) of heat shock protein 60-*Eco*RV or glycosylphosphatidylinisotol-*Hha*I ([@B22]), PCR-RFLP of COll-*Alu*l ([@B04]) and PCR with TCC/TC1/TC2 primers designed in the SL-IR ([@B18]), as shown in [Fig. 1A](#f01){ref-type="fig"}.

Fig. 1:Lanes 1-14 in A and B contain the same *Trypanosoma cruzi* I strains or clones. A: differentiation between *Trypanosoma cruzi* I and *T. cruzi* II using TCC/TC1/TC2 primers (Souto et al. 1996). 1-14: *T. cruzi* I (350 bp); 15: *T. cruzi* II (300 bp); M: 100 bp ladder; 1: MHOM/C0/04/MG strain; 2: CG clone 1; 3: ORT15 Rcol strain; 4: Rcol clone 03; 5: Rpal clone 139-2; 6: Rpal clone 89-2; 7: Rpro (sylvatic) clone 8; 8: Rpro (sylvatic) clone 10; 9: D1 ( *Didelphis* ) strain; 10: D2 ( *Didelphis* ) strain; 11: X1081 Rpro (domestic) strain; 12: X1082 Rpro (domestic) strain; 13: CG clone 13; 14: EH strain; 15: *T. cruzi* II (300 bp); B: genotyping *T. cruzi* I strains and clones using a single pair of primers (1Am/1B) designed in the spliced-leader intergenic region. Domestic strains were identified by amplifying a 231 bp fragment and sylvatic strains were identified by amplifying a 450-550 bp fragment. M: 100 bp ladder; 1: MHOM/C0/04/MG strain; 2: CG clone 1; 3: ORT15 Rcol strain; 4: Rcol clone 03; 5: Rpal clone 139-2; 6: Rpal clone 89-2; 7: Rpro (sylvatic) clone 8; 8: Rpro (sylvatic) clone 10; 9: D1 ( *Didelphis* ) strain; 10: D2 ( *Didelphis* ) strain; 11: X1081 Rpro (domestic) strain; 12: X1082 Rpro (domestic) strain; 13: CG clone 13; 14: EH strain; M: 100 bp ladder.

All PCR reactions were conducted for 35 amplification cycles using a thermal minicycler (MJ Research PTC-150-16). Cycling include a denaturing step at 94ºC for 30 s (4 min for initial denaturing), annealing at 51ºC for 30 s, extension at 72ºC for 30 s and a final extension step at 72ºC for 10 min.

After standardising the reaction conditions using the previously described primers, the TcI~DOM~ and clones produced the expected 231 bp amplification product; however, the sylvatic clones and strains produced 450-550 bp amplification products when using the same primers ([Fig. 1B](#f01){ref-type="fig"}). Several *T. cruzi* I samples and clones isolated from sylvatic triatomines and reservoirs produced the 450-550 bp profile, as shown in [Fig. 1B](#f01){ref-type="fig"}. The ORT15 strain, isolated by xenoculture from a rectal ampulla from *R. colombiensis* in the department of Tolima, was correctly typed after its isolation in February 2013 ([Fig. 1B](#f01){ref-type="fig"}, Lane 3). *T. cruzi* I clones from the intestinal contents of *R. colombiensis*, *R. pallescens* and sylvatic *R. prolixus*, obtained by direct plating in a sensitive solid medium ([@B23]), produced the 450-550 bp profile ([Fig. 1B](#f01){ref-type="fig"}, Lanes 4-8). The D1 and D2 strains, isolated from *Didelphis marsupialis* and maintained in culture in biphasic medium, also produced the sylvatic profile ([Fig. 1B](#f01){ref-type="fig"}, Lanes 9, 10). The existence of mixed profiles in *T. cruzi* I strains is possible, as 175 of 182 (96.2%) clones obtained from sylvatic *R. colombiensis*, *R. pallescens* and *R. prolixus* produced the 450-550 bp profile and seven of these 182 clones (3.8%) produced a 231 bp profile (data not shown). These results support the assertion that the 450-550 bp profile is predominant in sylvatic cycles.

Alternately, MHOM/CO/04/MG, a human strain that is maintained by periodic passages in mice, produced the 231 bp profile ([Fig. 1B](#f01){ref-type="fig"}, Lane 1) as did two human CG strain clones ([Fig. 1B](#f01){ref-type="fig"}, Lanes 2, 13). Three domestic samples had mixed profiles. The X-1081 and X-1082 strains, which were isolated by xenoculture from the intestinal content of domiciliated *R. prolixus* in the department of Boyaca and kept in culture for several years, displayed the 231 and 450-550 bp profiles ([Fig. 1B](#f01){ref-type="fig"}, Lanes 11, 12). A similar mixed profile was observed in the human EH strain (Lane 14), suggesting a mixed infection of both genotypes, as previously reported by [@B17].

Domestic or sylvatic reservoirs may also select for subpopulations within *T. cruzi* I. The possibility that domestic or sylvatic vectors may selectively transmit *T. cruzi* I genotypes cannot be excluded, as the selective transmission of both *Trypanosoma rangeli* genotypes has been demonstrated for various *Rhodnius* species ([@B12], [@B21], [@B19]).

When diagnostic or molecular characterisation techniques are developed, it is necessary to verify that the technique is specific to *T. cruzi* and demonstrate a lack of cross-reaction with *T. rangeli*, as *T. rangeli* frequently occurs in mixed infections with *T. cruzi* in triatomines and in vertebrate reservoirs in Colombia. We emphasise that the purpose of this work was to use a PCR reaction with 1Am/1B primers in strains that had previously been typed as *T. cruzi* I *sensu lato* and thus we initially used strains or clones that were previously characterised as *T. cruzi* I. Nevertheless, because mixed *T. rangeli* infections in vectors and vertebrates can be found in nearly all *T. cruzi*-endemic areas in Colombia, strains can therefore be isolated together with *T. cruzi* I and *T. rangeli. T. rangeli* DNA and 1Am/1B primers, which did not produce any amplification products, were used as controls to rule out cross-reactions (data not shown).

Our results demonstrated that Colombian domestic and sylvatic *T. cruzi* I strains can be discriminated using a single PCR amplification of the SL-IR from TcI~DOM~ (formerly TcIa/VEN~DOM~) and sylvatic strains. Nine isolates from patients suffering acute Chagas disease involving different transmission routes and different clinically diagnosed symptomatology were used to verify whether this single PCR reaction could be used to discriminate between *T. cruzi* I infections of TcI~DOM~ and sylvatic genotype origin. Six of the nine isolates had the sylvatic profile, corresponding to three cases of acute myocarditis in outbreaks of oral transmission (Santander, Colombia), a congenital case (Santander, Colombia) and two cases of sylvatic vector transmission (Putumayo, Colombia) ([Fig. 2](#f02){ref-type="fig"}). The remaining three cases were identified as *T*. *cruzi* II when using D71/D72, V1/V2 primers ([@B01]). *T. cruzi* II was found in two congenital cases (Boyaca, Colombia), as previously described ([@B10]), and in a case of reactivation caused by human immunodeficiency virus/acquired immune deficiency syndrome (Caquetá, Colombia). Human *T. cruzi* strains were isolated by haemoculture during the acute phase of infection and were typed long after isolation and thus there was no patient follow-up to obtain new isolates for further characterisation. Selection among *T. cruzi* genotype mixtures when maintained in culture or in animal models could not be ruled out, as selection towards TcII in mixed infections with TcI strains (with subtle TcII parasites or clones) has been reported ([@B11]). Our single PCR reaction for discriminating *T. cruzi* I genotypes could be of great use for determining the genotype frequency as well as follow-up analyses comparing the profiles of initially isolated genotypes with their later stability or selection after maintenance in culture or biological models for varied lengths of time.

Fig. 2characterisation of human isolates using 1Am/1B primers. Lanes 1-2 contain the same samples of MHOM/CO/03/CG C1 clone of human origin and Lanes 3-8 contain the strains SMA, XCH, JEM, YLY, EH, HMriv isolated from acute cases of Chagas disease in Colombia.

The results of this present study corroborated previous reports by [@B17] highlighting the fact that the sylvatic *T. cruzi* I genotype is implicated in oral and sylvatic vector transmission in Colombia. New studies involving a greater number of human isolates should further support these observations.

In summary, after *T. cruzi* I has been diagnosed in any isolate, we propose that an additional PCR reaction be used with a single pair of primers for discriminating between TcI~DOM~ and sylvatic *T. cruzi* I. This methodology has led to the identification of the genotypes involved in outbreaks of oral Chagas disease as well as supporting studies of the transmission dynamics of *T. cruzi* as the causal agent of Chagas disease in Colombia. Our results agree with those of other investigators reporting that *T. cruzi* I encompasses two main groups that, to date, are not known to be stable in time and space. Further investigation will be useful for verifying population selection within hosts and detecting the frequency of mixed genotypes of *T. cruzi* I in Colombia.
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